Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age

StatusActive
Effective start/end date5/08/164/08/21

Funding

  • Sanofi Pasteur, Inc.: $112,325.00

Keywords

  • Biotechnology &amp; Drug Development, Immunology